Common antibiotic could block deadly infection in vulnerable liver patients
NCT ID NCT04153604
Summary
This study looked at whether the antibiotic doxycycline can safely prevent a serious abdominal infection called spontaneous bacterial peritonitis (SBP) in people with advanced liver disease. Researchers compared doxycycline to standard preventive medications in over 800 patients to see which was better at stopping the infection from coming back. The goal was to find a safe and effective alternative for long-term prevention, as current standard drugs can have significant side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Methodist Dallas Medical Center
Dallas, Texas, 75203, United States
Conditions
Explore the condition pages connected to this study.